Hi-Risk/Recurrent/Advanced PCa Video Chat, May 19, 2025
It’s GreatNonProfits time of year for AnCan participants! Each year we need 10 new endorsements to retain our GreatNonProfits Seal, so if you’re relatively new &/or have not endorsed us previously, now’s the time. Just click https://greatnonprofits.org/org/ancan-foundation and tell the short version of why you love AnCan Foundation…. THANK YOU!
President Biden’s Diagnosis
Exceptionally, the Moderators dedicated a few minutes at the beginning of the session to discuss Joe Biden’s denovometastatic hormone sensitive prostate cancer diagnosis disclosed late last week. AnCan recognizes that most of our particpants directly relate. Start around the 20 minute mark if you prefer to skip Rick Davis’ statement and reactions to President Biden’s diagnosis from those present.
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix, Blue Earth Diagnostic and Foundation Medicine.
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
All AnCan’s groups are free and drop-in … join us in person sometime!
Editor’s Pick: President Biden’s diagnosis; and, ctDNA testing (rd)
Topics Discussed
President Biden’s mHSPC Dx; younger T3b Newbie faces treatment decision; is ctDNA testing available to patients?; 3rd Pluvicto treatemtn brings heavy side effects; what to expect 2 months after starting a drug holiday; Orgovyx appeal continues; Gent with seizure/cardio issuestakes drug holiday and needs a cardio-oncologist; lowPSAl, pre-chemo Gent starts Pluvicto; should Gent with adrenal insufficiency add 5 mg prednisone?
Hi-Risk/Recurrent/Advanced PCa Video Chat, May 13, 2025
It’s GreatNonProfits time of year for AnCan participants! Each year we need 10 new endorsements to retain our GreatNonProfits Seal, so if you’re relatively new &/or have not endorsed us previously, now’s the time. Just click https://greatnonprofits.org/org/ancan-foundation and tell the short version of why you love AnCan Foundation…. THANK YOU!
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix, Blue Earth Diagnostic and Foundation Medicine.
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
All AnCan’s groups are free and drop-in … join us in person sometime!
Editor’s Pick: Pluvicto shows results after 2 treatments (rd)
Topics Discussed
Surgery vs RT choice for high risk Newbie; PARP failing BRCA1 Gent – what next .. 2nd opinion!; 6-wk testing schedule leads to stable PSA; doing well post recurrence treatment; argon laser beats hyperbaric chamber to treat RT proctitis for our USN diver; Dr. Oh says wait on HT; GU MO in S. Florida; Jevtana holds advnced disease but kidney causes hospitalization; GU MO recommendation at Langone, Madison; unclear recurrence needs Dr. Heath’s eye at Mayo, Rochester.
Hi-Risk/Recurrent/Advanced PCa Video Chat, May 5, 2025
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix, Blue Earth Diagnostic and Foundation Medicine.
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
All AnCan’s groups are free and drop-in … join us in person sometime!
Editor’s Pick: How to follow PARP-I for BRCA1 Gent (rd)
Topics Discussed
Setting up for recurrence treatment in Alberta, Canada; PSMA rules out Mx, but what about other pelvic issues – bone Bx to follow; debulk IMRT done – SBRT boost to follow; 2 Pluvicto sessions reveal good progress; 90 days max for vacay meds on Medicare; is darolutamide monotherapy enough?; will new test to replace PSA work for recurrence?; how long to PSA nadir on HT?; Tricare alone not enough – join Vets to learn how to dual enroll; Payer denies Orgovyx – what to do; Marine Chaplain can’t find his voice – so uses Chat!
Hi-Risk/Recurrent/Advanced PCa Video Chat, April 22, 2025
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix, Blue Earth Diagnostic and Foundation Medicine.
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
All AnCan’s groups are free and drop-in … join us in person sometime!
Editor’s Pick: If you’re thinking Pluvicto, consider TLX591 (rd)
Topics Discussed
Younger Newbie concerned how to speak with his teenager; doublet or triplet for Canadian; Capt. Jim appreciates Dr. John’s heart intro; rising PSA remains a mystery; if you’re thinking Pluvicto, consider TLX591; remission continues thanks to AnCan; concerned about tentacular involvement; just home from HDR brachy
Hi-Risk/Recurrent/Advanced PCa Video Chat, April 8, 2025
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix & Blue Earth Diagnostic.
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
All AnCan’s groups are free and drop-in … join us in person sometime!
Editor’s Pick: Testosterone superman deflates — and his shrine is dismantled — after he checks his math (bn).
Topics Discussed
Will a switch to estrogen outsmart the cancer?; he was slated for 3 years of ADT, but may want to quit or or ease off on year 3 — many options exist but not all are proven; third Pluvicto round for Marc V — he’s looking well, and Dr. Aggarwal’s feeling good about the results; the right way to taper off a bone strengthener; the story of CD46, a promising PCa marker for theranostics; spotlight’s back on hot flashes — as usual, many suggestions; he wants to resume his job the day after brachy — possible?; cardio-oncologist in Chicagoland?; testosterone superman deflates — and his shrine is dismantled — after he checks his math; off ADT, should he worry about rising T?; too early in the game for neuroendocrine worries; even if you need to wait for a scan, don’t start ADT without one; don’t sweat the small stuff when it comes to rising PSA; insufficiency fractures; what to expect during radiation treatment — Dr. Mark’s the expert.
Chat Log
AnCan – rick · 6:41 PM
How Cancer Cells Travel to New Tissues and Take Hold… https://www.medscape.com/s/viewarticle/how-cancer-cells-travel-new-tissues-and-take-hold-2025a10007rt?ecd=WNL_trdalrt_pos1_250407_etid7346797&uac=529807HK&impID=7346797
AnCan – rick · 7:24 PM
Here’s the Mayo paper by Brad Stish re. oxybutynin https://www.medpagetoday.com/meetingcoverage/asco/110457?xid=nl_mpt_DHE_2024-06-03&eun=g1169472d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=Daily%20Headlines%20Evening%202024-06-03&utm_term=NL_Daily_DHE_dual-gmail-definition&mc_cid=81fa35ee19&mc_eid=838454d636&mc_cid=1550e5c67f&mc_eid=838454d636
AnCan – rick · 7:27 PM
Forget that link – here’s the right one https://www.medpagetoday.com/meetingcoverage/asco/110457?xid=nl_mpt_DHE_2024-06-03&eun=g1169472d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=Daily%20Headlines%20Evening%202024-06-03&utm_term=NL_Daily_DHE_dual-gmail-definition&mc_cid=81fa35ee19&mc_eid=838454d636&mc_cid=1550e5c67f&mc_eid=838454d636
AnCan – rick · 7:30 PM
The culprit that makes oxyb. work better with abi is the CYP3A4
Steve Roux, North Michigan · 7:54 PM
I’m late for dinner. GREAT Mtg guys! See you next week!
John A · 8:14 PM
insufficiency fractures: result of normal stress on abnormal bone ….fatigue fx: abnormal stress on normal bone…. .pathological fx: diseased weakened bone due to tumors or abnormal bone . ….stress fx: means chronic mechanical stress exceeds the bone’s capacity
Bob Schwartz, USN, Venice FL · 8:15 PM
Another good mtg., have to go.
